Capromorelin (Tartrate)
Capromorelin Tartrate is an orally active, potent growth hormone secretagogue receptor (GHSR) agonist, with Ki of 7 nM for hGHS-R1a.
Product Specifications
CAS Number
193273-69-7
Product Name Alternative
CP 424391-18
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
GHSR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/Capromorelin_Tartrate.html
Purity
98.10
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C([C@@H]([C@@H](O)C(O)=O)O)O.CC(C)(N)C(N[C@H](COCC1=CC=CC=C1)C(N(C[C@]23CC4=CC=CC=C4)CCC2=NN(C)C3=O)=O)=O
Molecular Formula
C32H41N5O10
Molecular Weight
655.70
Precautions
H315, H319, H335
References & Citations
[1]Zollers B, et al. Capromorelin oral solution (ENTYCE?) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. BMC Vet Res. 2017 Jan 5;13 (1) :10.|[2]Carpino PA, et al. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs) . Discovery of capromorelin. Bioorg Med Chem. 2003 Feb 20;11 (4) :581-90.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog